ABOUT THIS PODCAST
The use of biotherapies has surged in recent years, creating new challenges and opportunities for pharmacy. In this episode, three experienced pharmacists in the world of biotherapeutic drugs will review key considerations for working with these agents. Their discussion will cover biosafety review processes and how to develop the structure to support ongoing management of biotherapeutics.
SPEAKERS
- Kayla Waldron, PharmD, MS, BCPS, FASHP
Director, Medication Use and Quality Improvement, ASHP - Kevin Zinchuk, PharmD, CCRP
Manager, Investigational Drug Service, Brigham and Women's Hospital - Kevin Anger, PharmD, BCPS
Pharmacy Director, Brigham and Women's Hospital - Anna Wiener, PharmD, MS
Program Manager, Pharmacy Regulatory Compliance, Quality Assurance, and Medication Safety
Children's Hospital of Philadelphia
